Long-term integrative personalized medicine care in massive brainstem hemorrhage: A CARE-compliant case report
Abstract
Rationale: Brainstem hemorrhage is a rare but devastating subtype of intracerebral hemorrhage that frequently presents with impaired consciousness, quadriplegia, and recurrent infections. Integrative personalized medicine care (IPMC), which combines essential conventional treatments with personalized traditional Korean medicine interventions, has been suggested to improve functional outcomes and support immune regulation. By closely monitoring a patient with massive brainstem hemorrhage treated with IPMC, we observed neurological improvement, effective control of recurrent infections and inflammation, and sustained safety of long-term herbal medications.
Patient concerns: A 48-year-old female patient with a brainstem hemorrhage was managed at Kyung Hee University Hospital with IPMC for posthemorrhagic functional impairment and recurrent infection.
Diagnoses: The patient was diagnosed with a massive pontine hemorrhage with posthemorrhagic functional impairment and recurrent infection.
Interventions: The patient received conventional treatment and integrative personalized traditional Korean medicine interventions, including herbal medications and acupuncture.
Outcomes: We retrospectively analyzed the 2-year clinical course of the patient who received IPMC to evaluate the efficacy and safety of the treatment. Functional outcomes and inflammation control were assessed using standardized scales (modified Barthel index, Korean mini-mental state examination, Glasgow Coma Scale,…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.